MedPath

To evaluate the safety and efficacy of Ahmadi anti-aging cream in skin rejuvenatio

Phase 2
Conditions
skin aging.
Registration Number
IRCT20190210042676N6
Lead Sponsor
Javansaz Ahmadi Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

In terms of wrinkles, the skin should be grade 2 or 3 according to the Glogau scale.
Signing the consent form for participation in the study

Exclusion Criteria

Volunteers should not use any cream other than sunscreen and moisturizer,during the study.
History of any type of cosmetic surgery over the past 3 years at the treatment site
History of using RF within the past year
History of botulinum toxin injection, laser or intense pulsed light within the past 6 months
Any immunodeficiency or use of immunosuppressive drugs (cancer, chronic liver and kidney disease, etc.)
Pregnancy or lactating
Active smoker in last 2 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changing in facial skin wrinkle using global aesthetic improvement scale. Timepoint: before intervention , 4 and 8 weeks later. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the global aesthetic improvement scale .
Secondary Outcome Measures
NameTimeMethod
Skin elasticity. Timepoint: before intervention and 4 and 8 weeks later. Method of measurement: Cutometery.;Area and volume of nasolabial fold. Timepoint: before intervention and 4 and 8 weeks later. Method of measurement: VisioFace.
© Copyright 2025. All Rights Reserved by MedPath